Abstract
Background
The importance of the ratio of creatinine to urinary protein, albumin, and low-molecular weight protein as a urinary marker in chronic kidney disease patients is widely recognized. However, no reference values have hitherto been established for these markers in Japanese children. The present study aimed to establish the reference values for these urinary markers in Japanese children.
Methods
The first morning urine was randomly collected from 1712 pupils aged ≥ 3 to < 18 years during school and kindergarten mass urinary screenings. The upper limit of the reference values was set at the 97.5th percentile of the creatinine ratio per marker.
Results
The urinary protein-to-creatinine ratio (PCR), urinary albumin-to-creatinine ratio (ACR), urinary beta 2-microglobulin-to-creatinine ratio (BMCR), and urinary alpha 1-microglobulin-to-creatinine ratio (AMCR) showed an age-related decrease at the 50th percentile reflecting an age-related increase in urinary creatinine. The appropriate reference value for the PCR and ACR was 0.12 g/gCr and 35 mg/gCr, respectively, in the entire cohort. The appropriate reference value for the BMCR was 0.5 μg /mgCr for age ≥ 3 to < 6 years and 0.35 μg/mgCr for age 6 years or older. The appropriate reference value for the AMCR was 5.0 μg/mgCr for age ≥ 3 to < 6 years and 3.5 μg /mgCr for age 6 years or older.
Conclusion
The present study was the first to determine appropriate reference values for the PCR, ACR, BMCR, and AMCR based on an analysis of the first morning urine samples of a large number of children.
Similar content being viewed by others
Introduction
The urinary protein-to-creatinine ratio (PCR) and urinary albumin-to-creatinine ratio (ACR) are essential for evaluating chronic kidney disease (CKD), and the importance of assessing urinary albumin in children is now attracting more attention. The 2012 Guidelines for CKD issued by Kidney Disease: Improving Global Outcomes (KDIGO) state that the urinary excretion of albumin is a risk factor of earlier deterioration of the glomerular filtration rate in pediatric patients as well as adults with CKD [1]. However, the same guidelines also indicate that there is no high-quality evidence for urinary albumin excretion in children, unlike for urinary protein excretion [1]. However, measuring low-molecular weight proteins in patients with congenital anomalies of the kidney and urinary tract (CAKUT) allows CKD progression to be evaluated [2,3,4,5]. Measuring the urinary excretion of low-molecular weight proteins is also recommended as means of detecting tubular diseases, such as Dent disease and nephronophthisis [1].
When evaluating CKD in children, the urinary Cr value and other markers need to be adjusted for age. However, as of yet no large-scale analysis of the PCR, ACR, urinary beta 2-microglobulin-to- creatinine ratio (BMCR) or urinary alpha 1-microglobulin-to-creatinine ratio (AMCR) has been conducted.
The present study aimed to establish age-appropriate reference values for the PCR, ACR, BMCR, and AMCR for the Japanese pediatric population.
Materials and methods
Materials
In Japan, the regional education boards and schools have had the responsibility of conducting annual school urinary screening for five decades. The screening is usually done in April at the start of each school year. Samples of the first morning urine are tested at testing centers designated by the regional education boards.
Study sample
In the present study, an equal number of urine samples were collected from each age group and sex at screenings between April 8 and May 14, 2014. The subjects ranged in age ≥ 3 to < 18 years. The parameters for random selection were based on 333,411 urine samples analyzed by the Tokyo Health Service Association (THSA) in 2014. In total, 1712 samples, including samples from 866 male and 846 female subjects, were collected for the present study in cooperation with the THSA, which has been carrying out urinalysis for schools and kindergartens in wide areas of Tokyo prefecture. The Clinical Research Support Center at Tokyo Metropolitan Children’s Medical Center conducted the randomization and management of the samples. The data center informed the THSA about the urinalysis schedule, name of the screening venues, subjects’ age, sex, and expected sample number in advance and randomly selected the facilities, etc., to ensure that more than 50 samples were obtained per age group and sex.
Measuring methods
Measurement of urinary creatinine (U-Cr), protein (U-Prot), albumin (U-Alb), beta 2-microglobulin (U-BMG), and alpha 1-microglobulin (U-AMG) was done within ten hours after collection. The urinary protein and albumin values were measured using the pyrogallol red method (Micro TP-AR, Eiken Chemical Co., Ltd., Tokyo) and immunonephelometry (LZ test U-ALB, Eiken Chemical Co., Ltd., Tokyo), respectively. Beta 2-microglobulin and alpha 1-micoroglobulin were measured using latex nephelometry (using LZ test β2-M and LZ test α1-M, Eiken Chemical Co., Ltd., Tokyo), and creatinine was measured using the enzymatic method. All measurements were performed by the Tokyo Health Service Association.
Statistical analysis
The ratio of creatinine to urinary protein, albumin, beta 2-microglobulin, and alpha 1-mciroglobulin was calculated for each subject. The 97.5th percentile was established as the upper limit for the laboratory measurements in accordance with the recommendation of the Clinical and Laboratory Standards Institute [6]. The subjects were divided into the ≥ 3- to < 6-year-old, ≥ 6- to < 12-year-old, and ≥ 12- to < 18-year-old age groups corresponding to the pre-school age, pre-pubertal age, and adolescence, respectively. To establish clinically simplified reference values, percentile ranks were calculated for PCR, ACR, BMCR, and AMCR values per age group in considering values of approximated 97.5th percentiles. JMP15.2.1 “SAS Institute Japan” and EZR4.0.3 [7] were used for all statistical analyses. The Kruskal–Wallis test was used to compare the marker values among the age groups, and the Steel–Dwass method was used to adjust for multiplicity. The Mann–Whitney U test was used to assess differences between the sexes.
Results
Table 1 shows the exact number of samples included in the present study. The samples were allocated evenly among the age groups and between the sexes. In total, 1712 samples comprising more than 50 and less than 78 samples per sex and age group were included for analysis.
Figure 1 shows a box-and-whisker diagram with logged data for U-Prot, U-Alb, U-BMG, and U-AMG, and Fig. 2 shows a box plot with logged data for the PCR, ACR, BMCR, AMCR, and U-Cr per age. Compared to the data in Fig. 1, the data in Fig. 2 show a general decrease in PCR, ACR, BMCR, and AMCR values with increasing age, which was reflected by increased urinary creatinine. Data on each marker and each marker divided by Cr were examined separately for each age group (Table 2 and Supplementary table). Table 2 shows the 50th, 90th, 95th, 97.5th, and 99th percentiles for the PCR, ACR, BMCR, and AMCR per age group. The Kruskal–Wallis test and Steel–Dwass test used to analyze the difference among these markers per age group demonstrated a significant decrease in all the markers with increasing age (p < 0.001). BMCR and AMCR clearly had a higher value for the 97.5th percentile in the ≥ 3- to < 6-year-old age group, unlike PCR and ACR.
Table 3 shows the results of the statistical analysis by sex. Male subjects in the ≥ 12- to < 18-year-old group tended to have a higher level of low-molecular weight proteins (BMCR and AMCR), and female subjects in the ≥ 6- to < 12- and ≥ 12- to < 18-year-old groups tended to have a higher ACR.
Percentile ranks were calculated for PCR, ACR, BMCR, and AMCR per age group to determine the simplified reference values (Table 4). For PCR and ACR, 0.12 g/gCr and 35.0 mg/gCr was approximated to the 97.5th percentile per age group. On the other hand, for BMCR, 0.35 μg/mgCr was approximated to the 97.5th percentile for the group aged 6 years or more while 0.5 μg /mgCr was closer to the 97.5th percentile for the group aged ≥ 3 to < 6-years. For AMCR, 3.5 μg /mgCr was closer to the 97.5th percentile for the group aged 6 years or more, while 5.0 μg /mgCr was closer to the 97.5th percentile for the group aged ≥ 3 to < 6 years. Each of these values was adopted as a reference value.
Discussion
The present study established a reference value of 0.12 g/gCr for the PCR for the entire cohort; the Japanese Society of Nephrology’s adult reference value for PCR is 0.15 g/gCr. The appropriateness of the PCR reference value was particularly clear for those aged 6 years or older. The KDIGO guidelines and Nelson Textbook of Pediatrics recommend an ACR reference value of 30 mg/gCr [1, 8]; however, the findings of the present study suggest that 35 mg/gCr may be more appropriate for children older than 3 years. Until now, no reference values for the BMCR or AMCR have been published. The present study, which is the only large-scale study of these markers in the pediatric population to date, found that 0.5 μg /mgCr for the 3- to 5-year-old group and 0.35 μg /mgCr for children 6 years or older are adequate as reference values for the BMCR, while 5.0 μg /mgCr and 3.5 μg /mgCr are adequate as reference values for the AMCR for the respective groups. The result of dividing each value by the creatinine value is more important in clinical practice for reducing the effects of urine concentration. Moreover, the age difference in these markers becomes more apparent when their value is divided by the creatinine value, thereby yielding age-weighted values.
The Clinical and Laboratory Standards Institute recommends the 97.5th and the 2.5th percentiles as the upper and lower limits of the reference range, respectively [6]. The present study was able to establish the 97.5th percentile as an appropriate reference value for the PCR, ACR, BMCR, and AMCR (Table 2). Our data indicated that lower percentile figures were more appropriate for the BMCR and AMCR in the oldest age group; thus, specifying the reference value per age group may be necessary to avoid underdiagnosing kidney diseases even if thus far no studies have examined the need to adjust the reference values for age.
In previous guidelines and textbooks, the reference values for the PCR fell between 0.15 g/gCr and 0.2 g/gCr. The 2012 CKD guidelines published by KDIGO suggest that the PCR reference value should be < 0.2 g/gCr in the first morning urine in children older than 24 months [1]. The Nelson Textbook of Pediatrics also recommends 0.2 g/gCr Cr as the normal range for the PCR in the first morning urine in children older than 2 years [8] based on a study by Hogg et al. [9]. Our data suggested that modifications were necessary to establish reference values for the Japanese pediatric population, and in the present study the 97.5th percentile was adopted as an appropriate reference value most closely approximating in the percentile ranks. According to our data, the percentile rank at 0.15 g/gCr for the PCR fell between the 98th to 99th percentile per age group (Table 4), suggesting that the reference value of 0.15 g/gCr may lead to underdiagnosis of kidney diseases in older children. The reference value of 0.12 g/gCr may be more appropriate for all age groups, as shown in Table 4.
The conditions under which urine samples are collected affect the PCR value. The KDIGO guidelines and the Nelson Textbook of Pediatrics suggest collecting the first morning urine to rule out false positive results due to orthostatic proteinuria [1, 8]. Thus, in the present study, only the first morning urine collected at school screenings was used for analysis.
To date there are no studies of the ACR reference value for Japanese children. Based on the definition of albuminuria of the Nation Health and Nutrition Examination Survey III (NHANES III) [10], the KDIGO guidelines recommend an ACR reference value < 30 mg/gCr. The present study found the 97.5th percentile for ACR to fall between Cr 32 mg/gCr and 35 mg/gCr for all three age groups; based on this finding, 35 mg/gCr was chosen as an adequate ACR reference value (Table 4).
Low-molecular weight proteins can be markers of tubular injury or disorders and tend to occur at high levels in CAKUT, according to some previous studies [2,3,4,5, 11]. Assadi et al. found a correlation between the severity of vesicoureteral reflux and urinary BMG excretion [2]. Radhakrishna et al. found that 64% of patients with CAKUT had high urinary BMG excretion [5]. Although CAKUT is not generally considered a tubular disease, the primitive duct is characteristic of dysplastic kidneys and the involvement of the tubules and interstitium is widely recognized in several types of advanced CAKUT. These features may explain the increase in the excretion of low-molecular weight proteins in other CAKUT phenotypes. Although age-related adjustment of the reference values has yet to be done, a previous report by Hibi et al. [12] found evidence of changes related to age. In the present study, a decrease in the 50th percentile value due to the increasing excretion of U-Cr with age was observed for each marker (PCR, ACR, BMCR, and AMCR), and a clear, increasing tendency in the 97.5th percentile value of the BMCR and AMCR was observed in the youngest age group. Thus, it is appropriate to establish a discrete reference value for the AMCR and BMCR for these age groups. Table 4 shows the percentile rank for the PCR, ACR, BMCR, and AMCR in our study. Based on these data, we recommend 0.5 μg/mgCr and 0.35 μg /mgCr as a reference value for BMCR and 5.0 μg /mgCr and 3.5 μg/mgCr as a reference value for AMCR in the 3- to 5-year-old group and children 6 years or older, respectively.
Our study found differences by sex in the ACR, BMCR, and AMCR in the two, older age groups. A lower ACR in male subjects was reported by Muller et al. in 1999 [13], but this finding was not used to establish a range of appropriate reference values. The older male subjects in the present study had a higher AMCR, possibly as a result of higher serum α1-microglobulin [14]. However, no sex-related difference in serum or urine beta 2-microglobulin has been reported. CKD-related morbidities apparently differ by sex, but further study of CKD patients is needed to verify this finding.
The present study has several limitations. The urine samples were collected only in Tokyo; hence, there may be a sampling bias. However, the samples were taken from a wide swath of Tokyo, including rural areas. Hence, the differences in locality may not be meaningful. Children with kidney disease were not included in the present study. However, most of these children do not take part in mass school urinary screenings in Japan, and their exclusion therefore is unlikely to have affected the results of the present study.
Conclusion
The present study established reference values for the PCR, ACR, BMCR, and AMCR in Japanese children by analyzing a large pediatric cohort. The present study is the first study of its kind to analyze the Japanese pediatric population and will be extremely useful for future clinical practice.
Change history
21 October 2023
A Correction to this paper has been published: https://doi.org/10.1007/s10157-023-02410-5
References
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO. Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. 2012;2013(3):1–150
Assadi FK. Urinary beta2-microglobulin as a marker for vesicoureteral reflux. Pediatr Nephrol. 1996;10:642–4.
Matsutani H. Measurement of beta 2 microglobulin in dried urine spotted on filter paper by means of a forward sandwich enzyme-linked immunosorbent assay. Pediatr Nephrol. 1992;6:135–9.
Morohashi T. Beta 2-microglobulin measurement with dried urine spots for congenital anomalies of the kidney and urinary tract screening in 3-year-old children. Pediatr Int. 2022. https://doi.org/10.1111/ped.15077.
Radhakrishna V. Clinico-biochemical profile of children with congenital anomalies of the kidney and urinary tract: a cross-sectional study. Kidney Dis. 2019;5:51–7.
Clinical Laboratory Standards Institute. Defining. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline-Third Edition. CLSI document C28-A3. Clinical and Laboratory Standards Institute, Wayne, Pa, USA, 2008.
Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transpl. 2013;48:452–8.
Francesco X. Clinical Evaluation of the Child with Proteinuria. In: Kliegan RM, St Geme III JW, Blum NJ, Shah SS, Tasker RC, Wilson KM, Behrman RE. Nelson Textbook of Pediatrics 21st ed. Elsevier. 2019.
Hogg R. Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a Pediatric Nephrology Panel Established at the National Kidney Foundation Conference on Proteinuria, Albuminuria, Risk Assessment, Detection, and Elimination (PARADE). Pediatrics. 2000; 105:1242–1249
Jones CA. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2002;39:445–59.
Hamada R. Urine alpha 1-microglobulin-to-creatinine ratio and beta 2-microglobulin-to-creatinine ratio for detecting CAKUT with kidney dysfunction in children. Pediatr Nephrol. 2022. https://doi.org/10.1007/s00467-022-05577-3.
Hibi Y. The ratios of urinary β2-microglobulin and NAG to creatinine vary with age in children. Pediatric Int. 2015;57:79–84.
Mueller PW, Caudill SP. Urinary albumin excretion in children: Factors related to elevated excretion in the United States population. Ren Fail. 1999;21:293–302.
Itoh Y. Sex differences in urinary alpha 1-microglobulin value in normal individuals. Nephron. 1991;57:121–2.
Acknowledgements
The authors would like to thank the technicians at THSA for assisting with the randomization of the sample selection and laboratory work. They would also like to thank Eiken Chemical Co., LTD. for providing the assay kits and technical support in carrying out the specimen analysis. They would also like to thank James Robert Valera for his assistance with editing this manuscript.
Funding
This study was supported by Health Research on Children, Youth and Families, a Health, Labour and Welfare Sciences Research Grant (H25-jisedai-ippan-003).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
All the authors contributed to the study conception and design. Material preparation and data collection and analysis were performed by Shojiro Okamoto, Takeshi Matsuyama, Riku Hamada, Yoshihiko Morikawa, Masako Tomotsune, Tetsuji Kaneko, Katsumi Abe, Atsushi Uchiyama, and Masataka Honda. Data analysis was performed by Shojiro Okamoto, Yoshihiko Morikawa, Masako Tomotsune, Tetsuji Kaneko, and Masataka Honda. The first draft of the manuscript was written by Shojiro Okamoto and Masataka Honda, and all the authors have commented on previous versions of the manuscript. All the authors have read and approved the final version of the manuscript.
Ethical approval
All procedures involving human participants were done in accordance with the guidelines for epidemiological studies issued by the Ministry of Health, Labour and Welfare of Japan (IRB approval #1 at Fussa Hospital and #25–33 at THSA) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed consent
As this study involved no risk to the subjects, was highly beneficial to them, and could not be accomplished by other means, the Ethics Committee of the research institution allowed individual informed consent to be waived in accordance with the "Ethical Guidelines for Epidemiological Research (2013)" published by the Japanese Ministry of Health, Labour and Welfare. A research prospectus, including the use of specimens and a statement of the right not to participate, was made available on the Fussa Hospital and THSA websites in accordance with the Japanese guidelines.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The original online version of this article was revised: In the original publication, one of the abbreviations was incorrectly typed in the Results section of the Abstract. The text “urinary beta 2-microglobulin-to-creatinine ratio (AMCR)” has been revised to read “urinary beta 2-microglobulin-to-creatinine ratio (BMCR)”. Furthermore, there were some extraneous elements in Table 2 and Table 4. In Table 2, the “e” at the bottom of the “Percentile” column has been removed. In Table 4, the redundant age range descriptions (≥ 3- to < 6-year-olds; ≥ 6- to < 12-year-olds; ≥ 12- to < 18-year-olds) have been deleted, and the alignment has been corrected.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
This article is published under an open access license. Please check the 'Copyright Information' section either on this page or in the PDF for details of this license and what re-use is permitted. If your intended use exceeds what is permitted by the license or if you are unable to locate the licence and re-use information, please contact the Rights and Permissions team.
About this article
Cite this article
Okamoto, S., Matsuyama, T., Hamada, R. et al. Reference values for urinary protein, albumin, beta 2-microglobulin, and the alpha 1-microglobulin-to-creatinine ratio in Japanese children. Clin Exp Nephrol 28, 50–57 (2024). https://doi.org/10.1007/s10157-023-02392-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10157-023-02392-4